comparemela.com

Page 25 - Bharat Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Safety first , says Bharat Biotech amid AstraZeneca row | India News

India News: NEW DELHI: Bharat Biotech on Thursday assured Covaxin's safety amid debate over Astrazeneca's admission that its Covid-19 vaccine, sold as Covishield .

Jamie scottSerum institute of indiaUniversity of oxfordMinistry of healthBharat biotechSerum instituteThrombocytopenia syndromeNdia newsNdia news todayOday newsGoogle newsReaking news

Bharat Biotech Highlights Covaxin s Safety First Feature Amid AstraZeneca s Covishield Row Over Side Effects

Bharat Biotech Highlights Covaxin s Safety First Feature Amid AstraZeneca s Covishield Row Over Side Effects
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.

United kingdom basedBharat biotech

In Public Interest : Bharat Biotech Affirms Covaxin Safety Amid AstraZeneca Debate

Bharat Biotech said all the studies and safety follow-up activities demonstrated "excellent safety record, without any vaccine-associated incidents of blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc"

City ofUnited kingdomNational institute of virologyIndian council of medical researchSerum institute of india covishieldBharat biotechThrombocytopenia syndromeIndian councilMedical researchNational instituteSerum instituteLok sabha electionKey candidates and constituencies at news

Bharat Biotech stresses on Covaxin s safety record after AstraZeneca admits to Covishield causing rare clotting side effects

Bharat Biotech stresses on Covaxin s safety record after AstraZeneca admits to Covishield causing rare clotting side effects
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

United kingdomAndhra pradeshOxford universitySerum institute of indiaAfter astrazenecaThrombocytopenia syndromeBharat biotechPune based serum institute

Covaxin Has Excellent Safety Record, Says Bharat Biotech

HYDERABAD Bharat Biotech on Thursday said that its Covid-19 vaccine Covaxin has an excellent safety record without any vaccine-associated incidents of blood

Andhra pradeshOxford universitySerum instituteBharat biotechPune based serum institute

vimarsana © 2020. All Rights Reserved.